AVITA Medical, Inc. (RCEL) Earnings History
Annual and quarterly earnings data from 1993 to 2025
Loading earnings history...
RCEL EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
RCEL Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 82.1% | 89.0% | -67.8% |
| 2024 | 85.8% | -88.1% | -96.3% |
| 2023 | 84.5% | -85.1% | -70.6% |
| 2022 | 82.4% | -79.9% | -77.5% |
| 2021 | 81.5% | -76.1% | -76.1% |
Download Data
Export RCEL earnings history in CSV or JSON format
Free sign-in required to download data
AVITA Medical, Inc. (RCEL) Earnings Overview
As of May 8, 2026, AVITA Medical, Inc. (RCEL) reported trailing twelve-month net income of -$49M, reflecting +27.2% year-over-year growth. The company earned $-0.17 per diluted share over the past four quarters, with a net profit margin of -67.8%.
Looking at the long-term picture, RCEL's historical earnings data spans multiple years. The company achieved its highest annual net income of $184,419 in fiscal 1996.
AVITA Medical, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including XTNT ($2M net income, -14.0% margin), TELA (-$39M net income, -54.6% margin), MDXG ($31M net income, 11.6% margin), RCEL has room to improve margins relative to the peer group. Compare RCEL vs XTNT →
RCEL Earnings vs Peers
Earnings metrics vs comparable public companies
RCEL Historical Earnings Data (1993–2025)
33 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$49M | +21.4% | $64M | $-1.74 | -67.8% | 89.0% |
| 2024 | -$62M | -74.8% | -$57M | $-2.39 | -96.3% | -88.1% |
| 2023 | -$35M | -32.7% | -$43M | $-1.40 | -70.6% | -85.1% |
| 2022 | -$27M | -6.1% | -$28M | $-1.57 | -77.5% | -79.9% |
| 2021 | -$25M | +5.4% | -$25M | $-1.03 | -76.1% | -76.1% |
| 2020 | -$27M | +36.8% | -$27M | $-2.07 | -90.9% | -90.8% |
| 2019 | -$42M | -67.4% | -$43M | $-3.00 | -294.7% | -299.2% |
| 2018 | -$25M | -45.9% | -$26M | $-1.12 | -458.6% | -466.4% |
| 2017 | -$17M | -49.5% | -$19M | $-1.85 | -1370.8% | -1489.9% |
| 2016 | -$12M | -12.1% | -$13M | $-1.72 | -975.0% | -1073.2% |
See RCEL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RCEL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RCEL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRCEL — Frequently Asked Questions
Quick answers to the most common questions about buying RCEL stock.
Is RCEL growing earnings?
RCEL EPS is $-0.17, with earnings growth accelerating to +27.2%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-49M.
What are RCEL's profit margins?
AVITA Medical, Inc. net margin is -67.8%, with operating margin at +89.0%. Below-average margins reflect competitive or cost pressures.
How consistent are RCEL's earnings?
RCEL earnings data spans 1993-2025. The accelerating earnings trend is +27.2% YoY. Historical data enables comparison across business cycles.